Results 151 to 158 of about 1,084 (158)

ChemInform Abstract: An Improvement to the Preparation of Prasugrel Hydrochloride (I).

ChemInform, 2013
Wenhua Ou, Weiyin Yi, Feng Liu, Xianhua Pan, Xijiang Peng   +4 more
openaire   +1 more source

Drug eruption due to prasugrel hydrochloride: A case report and mini‐review

The Journal of Dermatology, 2019
Midori Kawasaki‐Nagano, Risa Tamagawa‐Mineoka, Makoto Nakae, Yusuke Wakabayashi, Hiroki Nakagawa, Koji Masuda, Norito Katoh   +6 more
openaire   +1 more source

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction

Circulation, 2020
Giuseppe Gargiulo, Giovanni Esposito, Michael Nagler   +2 more
exaly  

Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Circulation, 2020
Alp Aytekin, Gjin Ndrepepa, Franz-Josef Neumann   +2 more
exaly  

Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

Circulation, 2016
Zuzana Motovska, Ota Hlinomaz, Roman Miklik   +2 more
exaly  

Prasugrel or Ticagrelor in ST-Segment–Elevation Myocardial Infarction Patients With Diabetes Mellitus

Circulation, 2017
Massimo Mancone, Riccardo Colantonio, Simone Calcagno   +2 more
exaly  

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Circulation, 2016
Francesco Franchi, Fabiana Rollini, Jung Rae Cho   +2 more
exaly  

Pharmacological, pharmacodynamics, and clinical profile of prasugrel hydrochloride (Efient(®) tablets 3.75 mg • 5 mg).

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Atsuhiro, Sugidachi, Atsushi, Kurihara, Kimihiko, Tanizawa, Takashi, Inoue   +3 more
openaire   +1 more source